India is one of Swiss drugmaker Novartis' most strategic growth markets, where it plans to launch a raft of innovative medicines, said Judith Love, president, APMA (Asia Pacific, Middle ...
Frankfurt: Novartis breast most cancers drug Kisqali minimize the risk of recurrence by a bit of greater than 25 per cent in a pivotal trial on girls recognized at ...
India ought to have a regulatory data protection system in place to attract basic drug analysis from main pharmaceutical corporations on the planet, Novartis Chief Executive Officer Vasant Narasimhan ...